Novo Nordisk acquires enzyme patents and know-how from Showa Denko.BAGSVAERD, Denmark; TOKYO--(BUSINESS WIRE)--Oct. 1, 1996--Novo Nordisk and Showa Denko Showa Denko K. K. (昭和電工株式会社 today announced that Novo Nordisk will acquire Showa Denko's patents and know-how related to industrial enzymes in connection with Showa Denko's decision to terminate activities in this field. "This deal will improve Novo Nordisk's position within some of our core enzyme technologies," says Steen Riisgaard, corporate executive vice president of Enzyme Business, Novo Nordisk. Novo Nordisk estimates the world market of industrial enzymes to be USD USD In currencies, this is the abbreviation for the U.S. Dollar. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 1.3 billion (in 1995), an increase of 15% in value compared to 1994. Showa Denko K K is one of the leading chemical manufacturers in Japan. The company's operations span olefins; organic, industrial, and specialty chemicals; gases; ceramics; carbons and metallic materials; aluminum and electronics. Showa Denko's net sales Net Sales The amount a seller receives from the buyer after costs associated with the sale are deducted. Notes: This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight for 1995 were USD 4.4 billion. Its headquarters is in Tokyo and it was established in 1939. Novo Nordisk A/S is the world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore, the company is the world's largest producer of industrial enzymes. Headquartered in Denmark, Novo Nordisk employs approximately 13,400 people in 54 countries and markets its products in 130 countries. Its B shares are listed on the stock exchanges in Copenhagen, London and Zurich. Its ADSs are listed on the New York Stock Exchange New York Stock Exchange (NYSE) World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City. under the symbol "NVO NVO no visible oestrus (see no visible estrus). Called also NVE. ". CONTACT: Novo Nordisk of North America Inc. Susan Toth Jackson, Corporate Communications Peter Baekgaard, Investor Relations Investor relations The process by which the corporation communicates with its investors. 212/867-0123 |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion